AuBiotech CEO Lorraine Chiroiu says the sector is very concerned by the decision to waive intellectual property protection for COVID-19 vaccines and treatments given what it says about the lack of understanding of its importance in attracting investment that ultimately supports innovation. …
AusBiotech's Lorraine Chiroiu: A 'hollow victory' and 'slap in the face'
July 18, 2022 Latest NewsBioPharmaAustralian BiotechBioPharmaDispatch ExecutiveNews of the Day
Latest Video
New Stories
-
Stakeholder backing for another PBS co-pay reduction
March 20, 2025 - - Latest News -
If our own government isn't going to do anything, then we can only hope for intervention
March 20, 2025 - - Latest News -
US price negotiation power reveals a very different approach to patient input
March 20, 2025 - - Latest News -
Brisbane-based drugmaker QBiotics celebrates 25 years since its creation
March 19, 2025 - - Australian Biotech -
Imugene's azer-cel granted FDA Fast Track Designation in blood cancer
March 19, 2025 - - Australian Biotech -
Island raises $2.72 million through exercise of listed options
March 19, 2025 - - Australian Biotech -
All manufacturers decide to participate in the second cycle of US price negotiation
March 19, 2025 - - Latest News